• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
OB
CMECNE

Twin Pregnancy: Ultrasound Evaluation and Monitoring

image_pdfFavoriteLoadingFavorite

Learning Objectives and CME/Disclosure Information

This activity is intended for healthcare providers delivering care to women and their families.

After completing this activity, the participant should be better able to:

1. State the ideal time to date a twin pregnancy using ultrasound
2. Discuss monitoring of twin pregnancies using ultrasound

Estimated time to complete activity: 0.5 hours

Faculty:

Susan J. Gross, MD, FRCSC, FACOG, FACMG President and CEO, The ObG Project

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


The PIM planners and others have nothing to disclose. The OBG Project planners and others have nothing to disclose.

Faculty: Susan J. Gross, MD, receives consulting fees from Cradle Genomics, and has financial interest in The ObG Project, Inc.

Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Method of Participation and Request for Credit

Fees for participating and receiving CME credit for this activity are as posted on The ObG Project website. During the period from 7/1/2019 through 1/25/2023, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon registering and successfully completing the post-test with a score of 100% and the activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The ObG Project. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Read Disclaimer & Fine Print

CLINICAL ACTIONS:

Twin pregnancies are followed more closely than singleton pregnancies due to higher risk for complications such as twin-twin transfusion syndrome, selective fetal growth restriction, and preterm labor. Ultrasound is a non-invasive and highly useful tool for screening, diagnosis, and guiding management of these potential complications. Ultrasound monitoring protocols vary between different types of twin pregnancies.

Zygosity, Chorionicity and Amniosity

  • Zygosity: Describes genetic origin of twins 
    • Dizygotic twins: Both twins originate from a separate oocyte and each oocyte is fertilized by its own spermatocyte
      • Will always be dichorionic and diamniotic
    • Monozygotic twins: Both twins develop from a single zygote which then cleaves to form two embryos
  • The timing of cleavage will determine chorionicity and amniosity of monozygotic twins
    • Approximately 2/3 monochorionic/diamniotic | 1/3 dichorionic/diamniotic | 1to 2% monochorionic/monoamniotic  
  • Chorionicity determines follow-up based on risks for adverse events

Image by Kevin Dufendach, MD (2008). Used by permission. CC BY 3.0

Dating (Ultrasound)

  • Ideal timing: Between 11w0d and 13w6d (45 and 84 mm)
    • Use CRL of the larger twin in spontaneously conceived twins
    • Use oocyte retrieval date or embryonic age from fertilization for twins conceived via IVF
  • Note: If a woman presents beyond 14 weeks gestational age then use head circumference of the larger twin (ISUOG)

Chorionicity Determination (Ultrasound)

  • Optimal timing to determine chorionicity by ultrasound is in the first or 2nd trimester
    • ACOG/SMFM recommend that chorionicity should be identified as early as possible
    • Ultrasound <13w6d may identify chorionicity in approximately 95% of cases based on membrane thickness and insertion
  • Dichorionic
    • Lambda (aka delta or twin peak) sign: Indicates dichorionic twins with thickening at membrane insertion site
    • 2 distinct placental masses
    • Discordant sex signifies dichorionic, diamniotic (and dizygotic) twins
  • Monochorionic
    • T sign: Indicates monochorionic twins, with thin membrane and absence of thickening at membrane insertion site
  • Note: A single placental mass does not rule out dichorionic twins

Lambda or Delta Sign Indicating Dichorionic Twins

© Nevit Dilmen Creative Commons Attribution-Share Alike 3.0 license https://creativecommons.org/licenses/by-sa/3.0/deed.en

T Sign Indicating Monochorionic Twins

© Nevit Dilmen Creative Commons Attribution-Share Alike 3.0 license https://creativecommons.org/licenses/by-sa/3.0/deed.en

Monitoring

Uncomplicated monochorionic twin pregnancy (see SMFM checklist in ‘Learn More – Primary Sources’ below)

  • 10 to 13 weeks:
    • NT | Size concordance
  • 16 weeks
    • AFV and bladder filling q2 weeks
    • Fetal growth q2 to 4 weeks
  • 18 to 22 weeks (earlier if possible)
    • Detailed anatomy and fetal echocardiogram
  • Antepartum surveillance (NST and/or BPP)
    • Monochorionic dichorionic: If fetal growth, AFV and bladder filling are all normal “there is no specific national recommendation regarding the need for, type of, or timing of surveillance”
    • Monochorionic monoamniotic: Initiation of surveillance typically at 32w0d | Clinicians may offer inpatient care starting at 24 to 28 weeks with daily surveillance but “optimal management remains uncertain” (ACOG)

Note: ISUOG guidelines do include umbilical artery Doppler monitoring as part of routine surveillance | ACOG/ SMFM considers evidence to be unclear for uncomplicate monochorionic twins

Uncomplicated dichorionic twin pregnancy

  • First trimester: Dating and chorionicity (see above)
  • 18 to 22 weeks: Detailed anatomy | Biometry | Amniotic fluid volume (AFV) | Cervical length
  • >20 weeks: q4 weeks until delivery: Fetal growth | AFV
  • 36w0d: consider weekly antenatal fetal surveillance

SYNOPSIS:

Most twin pregnancies will have good outcomes. However, diligence is required, especially in the case of monochorionic twins due to risk for twin-twin transfusion syndrome (TTTS) and twin anemia polycythemia sequence (TAPS). Monochorionic twins may have potentially significant vascular anastomoses such that the twins share a common vasculature. Significant risks for dichorionic twins include preterm labor, medical complications due to increased placental mass (e.g., preeclampsia and GDM) and selective growth restriction. Different centers will have different protocols for labeling twin A vs twin B. The important point is to be consistent with labeling.

KEY POINTS:

TTTS

  • 10 to 15% of monochorionic twins | 90% fetal demise if untreated
  • Diagnosis; AFV fluid imbalance noted on ultrasound
    • ‘Donor’ has oligohydramnios (DVP of < 2 cm) | ‘Recipient’ has polyhydramnios (DVP > 8 cm)

TAPS

  • Can occur spontaneously in approximately 5% of monochorionic diamniotic twins
  • Result of small AV anastomoses that leads to transfusion of blood from donor to recipient twin
    • At birth, anemia in donor and polycythemia in the recipient
  • Prenatal diagnosis based on MCA Doppler
    • Donor MCA‐PSV > 1.5 MoM | Recipient MCA‐PSV < 1.0 MoM

When to Deliver (ACOG/SMFM)

  • Multiple gestation – uncomplicated
    • Di-di twins: 38w0d – 38w6d
    • Mono-di twins: 34w0d – 37w6d
    • Mono-mono twins: 32w0d – 34w0d
    • Note: Triplets and higher: Individualize
  • Multiple gestation – complicated by isolated FGR
    • Di-di twins: 36w0d-37w6d
    • Mono-di twins: 32w0d-34w6d
    • Note: If concurrent condition: Individualize

When to Refer

  • Monochorionic/ Monoamniotic twins
  • Growth discordance: Defined as EFW discordance is ≥ 20% (ACOG)
    • Calculation: Difference in the estimated fetal weight between the two fetuses/ divided by the weight of the larger fetus
    • ISUOG uses a 25% cut-off
  • Any findings on ultrasound that are of concern

Primary Sources – Learn More:

ACOG/ SMFM Practice Bulletin 231: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies

SMFM Special Statement: Updated checklists for management of monochorionic twin pregnancy

ISUOG Practice Guidelines: role of ultrasound in twin pregnancy

ACOG SMFM Committee Opinion 831: Medically Indicated Late-Preterm and Early-Term Deliveries

Locate a Maternal Fetal Medicine Specialist

Maternal Fetal Medicine Specialist Locator-SMFM

Take a post-test and get CME credits

TAKE THE POST TEST

Want to be notified when new guidelines are released? Get ObGFirst!

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All OB Posts
Next >

Related ObG Topics:

ACOG Recommendations: When to Deliver Medically Complicated Pregnancies
How Accurate are Current Algorithms for Aneuploidy Screening in Twin Pregnancies
What is the Actual Relative Risk of Preeclampsia in Twins Compared to Singletons?
Do Twin-Specific Nomograms Really Make a Difference?
The MONOMONO Study: Inpatient or Outpatient Surveillance for Monochorionic/Monoamniotic Twins?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site